MOUNTAIN VIEW, Calif., July 16, 2014 /PRNewswire/ — Based on its recent analysis of industrial mobility applications in discrete industries, Frost & Sullivan recognizes Dassault Systemes with the 2014 Global Frost & Sullivan Award for New Product Innovation Leadership. Dassault Systemes’ unique manufacturing operations management solution, comprising the Apriso product portfolio, offers a unified framework and diverse set of applications to monitor and optimize operations across the production floor and extended supply chain.
Unlike most mobile solutions, which have been predominantly limited to field service, supply chain and warehouse management, the extended functionality of a DELMIA Apriso solution allows key enterprise personnel to view, control, and manage multiple production lines, facilities, business units, and plants across the globe.
The solution is finding increasing acceptance across discrete industries because of its seamless compatibility with multiple mobile platforms; cost-effective implementation using commercial, off-the-shelf devices; and user-friendly, role-based dashboards.
“As BYOD (bring your own device) takes precedence across discrete industries, the ability to use commercial mobile devices in complex industrial environments rather than expensive, industrial-grade tablets provides end users with a cost-effective approach to monitor their operational processes and equipment on the production floor,” said Frost & Sullivan Senior Research Analyst Rahul Vijayaraghavan. “Furthermore, the user-friendly interface of an Apriso solution allows diverse personnel across the facility to customize their dashboard to monitor and validate key performance indicators, such as line effectiveness, capacity requirements, utilization rates, and process efficiency.”
As manufacturing and production facilities continue to witness global expansions and new process additions, Dassault Systemes’ scalable framework to amass high volumes of data will foster greater market acceptance while providing a positive user experience.
“Using its manufacturing process intelligence (MPI) in conjunction with the online analytical processing (OLAP) database, Apriso solutions can streamline the collation of high-volume data from multiple plants and translate the data into profit insights — a key requirement in today’s competitive landscape,” said Frost & Sullivan Senior Research Analyst Srikanth MS. “Apriso’s manufacturing mobility solution has been successfully implemented in industries with intricate manufacturing processes, such as food and beverage (F&B) and aerospace and defense (A&D), which allows customers to manage shift changes appropriately, reduce downtime of operations, and facilitate end-to-end traceability.”
Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product. The award recognizes the value-added features of the product and the increased ROI, which, in turn, increases customer acquisition.
Frost & Sullivan’s Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development.
About Dassault Systemes & DELMIA
Dassault Systemes, the 3DEXPERIENCE Company, serves 190,000 customers across 140 countries, providing virtual universes for sustainable innovation. Dassault Systemes’ DELMIA brand offers products that connect the virtual and real worlds. As part of DELMIA, the Apriso product portfolio helps manufacturers transform their global operations to achieve and sustain operational excellence. Learn more at apriso.com, apriso.com/blog or follow us here: @Apriso.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies? Contact us: Start the discussion.
GUELPH, Ontario, July 16, 2014 /PRNewswire/ — Canadian Solar Inc. (the “Company”, or “Canadian Solar”) (NASDAQ: CSIQ), one of the world’s largest solar power companies, today released this statement on behalf of Thomas Koerner, General Manager of the …
SHANGHAI, July 16, 2014 /PRNewswire-FirstCall/ — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS), a global leader in the solar PV industry, today announced that it has entered into a five-year RMB1 billion strategic financing …
BEIJING, July 16, 2014 /PRNewswire/ — Changyou.com Limited (“Changyou” or the “Company”) (NASDAQ: CYOU), a leading online game developer and operator in China, and MoboTap Inc. (“MoboTap”), a Cayman Islands company that is the mobile technology develo…
First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program
HONG KONG, July 16, 2014 /PRNewswire/ — OrbusNeich today announced that the first patient has been enrolled in the Multinational Abluminal Sirolimus Coated BiO-Engineered StenT (MASCOT) post-marketing registry. The first COMBO™ Dual Therapy Stent implant was performed at the Amphia Hospital in Breda, The Netherlands.
Designed to assess the long-term safety and effectiveness of the COMBO Stent in routine clinical practice, the prospective, multicenter registry is the largest clinical study of the unique dual therapy stent to date, with a goal of 2,500 patients being followed for a year in up to 50 centers across Asia and Europe.
The study’s primary endpoint is device-oriented target lesion failure (TLF), defined as the composite of cardiac death, non-fatal heart attack (myocardial infarction or MI) not clearly attributable to a non-target vessel, or target lesion revascularization (TLR) from enrollment to 12 months.
The principal investigator is Prof. Antonio Colombo, M.D., San Raffaele Hospital, Milan, Italy; the director of the clinical coordinating center is Roxana Mehran, M.D., Mount Sinai Medical Center.
“Long-term safety remains an important area of clinical investigation with stents, particularly the avoidance of neoatherosclerosis and late stent thrombosis,” said Prof. Colombo. “The MASCOT registry will provide important information about the unique dual therapy approach of the COMBO Stent, which offers the possibility of functional arterial vessel healing, which we have not seen with any of the monotherapy drug eluting stents.”
“The clinical data gathered from COMBO stent trials to date show promise with respect to long-term safety and efficacy,” added Dr. Mehran. “For example, target lesion revascularization remained stable at 5.7 percent in both years two and three of the REMEDEE trial, with no thrombotic events over three years. If those results hold in the MASCOT registry, that will be good news for patients and cardiologists.”
OrbusNeich is supporting the COMBO Stent with one of the industry’s most robust clinical programs. In addition to the MASCOT registry, the REDUCE trial — which enrolled its first patient in June 2014 — aims to demonstrate the potential for a shorter period of dual antiplatelet therapy. Find more information on REDUCE here.
“The initiation of MASCOT, our largest registry trial to date, represents the commitment we have made to really understand the patient benefits of the COMBO Stent,” said B. Wayne Johnson, president and chief operating officer, OrbusNeich. “Only by delivering true vessel healing can patients feel safe for the long term. We expect the MASCOT trial to confirm what we have already seen with the COMBO Stent as it relates to vessel healing.”
14:17 | 16/07/2014
VGP – Industrial parks and processing zones in Ho Chi Minh City (HCMC) absorbed nearly US$ 265 million of FDI in the first half of 2014, of which 82% came to the garment and textile sector.
The HCMC Industrial and Export Processing Zone Management Board reported that the city lured a total of US$ 333.47 million in investment capital in the first six months (meeting over 60% of the year’s target). The figure posted a year-on-year increase of 55.49%.
In the January-June period, domestic investment valued over VND 1.4 trillion, up 1.2% against the same period last year with 37 newly-licensed projects.
Meanwhile, the city attracted US$ 264.67 million in FDI, representing a year-on-year increase of 80.69% with 19 newly-registered projects and 16 others increasing capital.
Noticeably, the FDI inflow focused on high-class fabric.
The management board also announced that they would establish two industrial parks specializing in auxiliary industries to serve the mechanic engineering, electronics and IT industries./.
By Kim Loan
New Reports From The Alzheimer’s Association International Conference® 2014 Show Progress In Early Detection, Identifying Risk Factors, And Treatment Trial Updates
COPENHAGEN, Denmark, July 16, 2014 /PRNewswire/ — New studies reported at the Alzheimer’s Association International Conference 2014 (AAIC® 2014) in Copenhagen cover the spectrum of Alzheimer’s disease and dementia research. Data includes advances in early detection and diagnosis, identifying risk factors and possible risk reduction strategies, and the first-ever long-term clinical trial of a multifaceted lifestyle change in older adults.
Also released at AAIC 2014 was new information on the basic brain science of Alzheimer’s, trends in new cases of dementia and overall numbers of people with the disease, the multiple benefits of cataract surgery for people with Alzheimer’s and additional data about drugs involved in Alzheimer’s prevention trials.
AAIC is the premier annual forum for presentation and discussion of the latest Alzheimer’s and dementia research. Bringing the world closer to breakthroughs in dementia science, AAIC 2014 brought together approximately 4,000 leading experts and researchers from 75 countries around the world, and featured more than 1,700 scientific presentations.
Potential for smell and eye tests in early detection of Alzheimer’s
Two studies from AAIC 2014 provide increasing evidence that the inability to correctly identify odors may indicate the development of cognitive impairment and Alzheimer’s disease. Based on smell identification tests, cognitive tests and brain size, researchers in one study of 215 elderly individuals found that loss of brain cell function and worsened memory were associated with smell identification ability. A second study of 757 individuals representing multiple ethnicities found that odor identification deficits were linked with an increased risk of transition from mild cognitive impairment (MCI) — a slight but noticeable and measurable decline in memory and thinking skills — to Alzheimer’s disease. For each point lower a study participant subject scored on a smell identification test, their risk for Alzheimer’s increased by about 10 percent.
Two additional studies looked at possible eye tests to detect Alzheimer’s. Preliminary results from one study, based on findings from 40 of the study’s 200 participants, suggest that there is a significant association between the level of beta-amyloid protein, the main component of Alzheimer’s brain “plaques,” in the brain and levels detected in the retina. Study participants took a proprietary supplement containing curcumin, which binds to beta-amyloid and has fluorescent properties that allow amyloid plaques to be detected on the retina of the eye with an advanced imaging technology. In another study, researchers used a new laser scanning system to measure beta-amyloid levels in the lenses of the eyes of 20 study participants with Alzheimer’s disease and 20 without the disease. When the scientists, who were unaware of the Alzheimer’s status of their subjects, compared amyloid levels based on the eye lens test to amyloid plaque buildup estimates from brain positron emission tomography (PET) scans, they were able to accurately differentiate those with Alzheimer’s disease from those without it.
Largest study of brain tau PET imaging suggests scans’ ability for early detection of dementia
The presence of “tangles” of abnormal tau protein in the brain is one of the defining characteristics of Alzheimer’s. When this protein becomes abnormal, it forms tangles of twisted fibers inside brain cells, which kills them. In a study of 52 cognitively normal seniors — the largest study of its kind to date — researchers found that tau buildup in several brain regions was closely linked with memory decline. Using a newly developed PET scan technology to “see” tau in the brains of living people, scientists found that study participants with higher levels of tau buildup in areas of the brain important to memory performed worse on memory tests over three years. The Alzheimer’s Association says the findings demonstrate the potential value of tau PET scans in early detection of dementia and in identifying participants for Alzheimer’s and dementia research studies.
Lifestyle interventions may improve memory and thinking in middle-age and older adults
A two-year randomized controlled clinical trial in Finland is the first to demonstrate that a structured program of multiple changes in lifestyle factors can improve memory and thinking in older adults at risk for cognitive impairment and Alzheimer’s. The 1,260 older adults in the trial, whose ages ranged from 60 to 77, were divided into two groups. One group received an intervention that included nutritional guidance, physical exercise, cognitive training, social activities and management of heart health risk factors, while the control group received only regular health advice. After two years, the intervention group performed significantly better on a comprehensive scale of memory and thinking, and on specific tests of memory and executive function (including planning, judgment and problem-solving).
A separate study of 329 cognitively normal middle-aged adults in the U.S. with a genetic predisposition or parental family history of Alzheimer’s found that participation in mentally stimulating activities in middle-age may help protect against the development of Alzheimer’s disease and dementia later in life. The researchers found that participants who self-reported a higher level of activities such as reading books and going to the museum, especially those who reported playing games like puzzles and cards more often, had higher test scores for memory and thinking challenges, such as planning, judgment and problem-solving. They also had greater volume in several brain regions involved in Alzheimer’s disease.
Exercise in mid- and late-life associated with decreased risk of dementia
Two studies reported at AAIC 2014 present evidence that regular physical activity may reduce the risk of Alzheimer’s and other dementias. In one study, 280 adults in the U.S. with a median age of 81 completed a questionnaire on the frequency and intensity of exercise during their lifetime. After observing the participants for about three years, the researchers found that a history of moderate physical exercise in middle age was associated with a significantly decreased risk of mild cognitive impairment (MCI). In a second study, researchers examined the frequency and intensity of exercise of 1,830 adults with normal cognition. The researchers found that light physical exercise in mid-life and late-life was associated with a decreased risk of MCI, as was vigorous physical exercise in mid-life and moderate physical exercise in late-life. The Alzheimer’s Association urges everyone to keep their brain healthy throughout their life. Tips and the latest research are at alz.org.
Late-onset high blood pressure could protect against dementia
While hypertension during midlife may increase risk for Alzheimer’s and other dementias, there is emerging evidence that its association with dementia risk may change over time, and may instead help protect against dementia in people age 90 and over. Researchers followed 625 older adults in the U.S. without dementia for up to 10 years and found that those with the onset of high blood pressure at age 80 to 89 had a significantly lower risk of developing dementia compared with participants with no history of high blood pressure. Those with the onset of hypertension at age 90 or older had even lower dementia risk.
Cataract surgery improves not only vision but cognition and quality of life
A small clinical trial in the U.S. found that cataract surgery for people with Alzheimer’s and other dementias not only improves vision but can slow decline in cognition and improve quality of life for both people with the disease and their caregivers. Preliminary analysis of results found that 20 participants who had surgery to remove cataract had significantly improved vision and quality of life compared to the eight participants who did not receive surgery. In addition, those who received the surgery experienced a reduced decline in memory and mental tasks such as planning, judgment, and problem-solving, as well as improvements in behavioral measures. Levels of perceived burden for caregivers of people in the surgical group showed improvement. The Alzheimer’s Association recommends that preferences about medical treatment and decisions should be addressed early in the disease process through the execution of advance directives.
Psychological intervention for caregivers may reduce anxiety and depression
A randomized controlled trial in the U.K. found that a psychological support program for family caregivers of people with dementia significantly reduced caregivers’ anxiety and depression, and the impact lasted for two years. In the trial, 260 family caregivers were divided into two groups. One group received standard care and the other received an intervention consisting of eight sessions that included education about dementia, caregiver stress and where to get emotional support, and techniques for dealing with caregiving challenges. Caregivers who received the eight-session intervention showed significantly better results on measures of depression, anxiety and cost of care. Researchers noted this may help caregivers stay in their role longer and provide more consistent care, which may delay placement of the person with dementia into a nursing home. The Alzheimer’s Association believes it is very important for caregivers to take care of themselves, and to reach out for help. Learn more at www.alz.org.
Diabetes drug associated with reduced risk of dementia
A study of a large German database of people age 60 or older who were free of Alzheimer’s and others dementias found that long-term use of the diabetes drug pioglitazone may reduce incidence of dementia. Researchers at AAIC 2014 presented the study, which examined more 145,712 subjects over six years. Results suggest that reduced risk of dementia was significantly associated with use of pioglitazone. Researchers noted one possible theory is the drug’s ability to suppress neuroinflammation.
Additional abnormal protein, TDP-43, found in brains of people with Alzheimer’s
Researchers identified that an abnormal protein, known as TDP-43, may play an important role in Alzheimer’s disease along with two previously identified proteins. Researchers examined the brains of 342 people identified after death as having Alzheimer’s-related changes for the presence, amount and distribution of TDP-43. More than half the brains had TDP-43. In addition, people with TDP-43 were ten times more likely to have been cognitively impaired at death than subjects without it. The scientists speculate that TDP-43 may help explain why some people have Alzheimer’s changes in their brain, but do not experience dementia. It is vitally important to fund basic research to learn more about Alzheimer’s disease, and to feed the front end of the therapy pipeline. The Alzheimer’s Association is the world’s leading nonprofit funder of Alzheimer’s disease research.
The Alzheimer’s Association International Conference (AAIC) is the world’s largest gathering of leading researchers from around the world focused on Alzheimer’s and other dementias. As a part of the Alzheimer’s Association’s research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community. Scientists leading the advancement of research gather to report and discuss the most current data on the cause, diagnosis, treatment and prevention of Alzheimer’s disease and related disorders.
About the Alzheimer’s Association
The Alzheimer’s Association is the world’s leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer’s. Visit www.alz.org or call 800.272.3900.
ATTN: Please refer to www.alz.org/aaic/press.asp or call (312) 335-4078 for individual stories included here that were presented before Wednesday, July 16, and have come off embargo.
Twentieth Century Fox Consumer Products and Village Roadshow Plan for World Class Theme Park in Korea
SEOUL, Korea, July 16, 2014 /PRNewswire/ — Governor Hong Joon-pyo, Gyeongsangnam-do Province, Jeffrey Godsick, president of Twentieth Century Fox Consumer Products, and Tim Fisher, CEO of Village Roadshow Theme Parks, announced the signing of Memorandum of Understanding (MoU) agreements to plan for Korea’s first international theme park and resort destination, Twentieth Century Fox World, at 11:00 KST, July 16, 2014 at the Foreign Correspondents’ Club of Korea Press Foundation. The proposed park will be part of a larger development in the Republic of Korea known as the Ungdong Entertainment Complex.
Initial plans for Twentieth Century Fox World Korea include a theme park spanning more than 75 acres of land and will be part of a 700 plus acre leisure resort and development that will bring to life a fully immersive entertainment experience featuring some of Fox’s most recognized and beloved film and television brands. The park will be located in the Ungdong Area of Busan-Jinhae Free Economic Zone, Jinhae-gu, Changwon City. Operating partner Village Roadshow, one of the leading independent entertainment companies in the world, joins the group as a design and development consultant, and the manager of the studio theme park.
“We are signing the agreements and moving forward with plans for our global theme park project with Twentieth Century Fox Consumer Products to develop a world-leading theme park and with Village Roadshow to operate the theme park. We will make every effort to successfully develop this global theme park through close cooperation with Fox and Village Roadshow. Once the theme park is completed, we expect more than 10 million foreign and local tourists will visit and the local economy will be boosted by creating 30,000 jobs, which is equivalent to attracting 100 manufacturing businesses,” said Governor Hong Joon-pyo.
“Korea provides a unique opportunity for an international theme park destination that will be incredibly attractive to both a thriving domestic consumer as well as a quickly growing tourist market from China, Japan and across Asia,” said Jeffrey Godsick, president of Twentieth Century Fox Consumer Products. “Our efforts in working with the Gyeongsangnam-do Provincial Government for a Twentieth Century Fox World theme park in the Republic of Korea illustrate our commitment to growing our global entertainment destination brand and a monumental step to further engage and connect with our audiences in key markets.”
“We are honored to work with Village Roadshow to develop a premiere theme park for the Republic of Korea that brings to life our globally-embraced film and television brands through richly themed environments and immersive and exciting narrative-based attractions,” said Greg Lombardo, vice president, global location based entertainment at Twentieth Century Fox Consumer Products.
“Village Roadshow Theme Parks is very excited to have the opportunity to work with the Gyeongsangnam-do Provincial Government and Twentieth Century Fox on the planning, design, development and operation of the theme park. With properties like Alien, Ice Age and Planet of the Apes, we believe this studio theme park will offer consumers in Korea and Asia the best theme park experience in the history of the industry,” said Tim Fisher, the CEO of Village Roadshow Theme Parks.
The announcement of the plans to develop Twentieth Century Fox World Korea joins a host of groundbreaking location based entertainment announcements from Twentieth Century Fox Consumer Products. Fox Consumer Products recently announced Fox’s first ever theme park, Twentieth Century Fox World, set to open in Malaysia in 2016. The park will feature a fully immersive entertainment experience featuring some of Fox’s most recognized and powerful film brands. Fox Consumer Products also announced the expansion of Springfield at Universal Studios Hollywood, coming in spring 2015, and has seen great success with the expansion of Springfield USA in August 2013, a full immersive experience for fans of The Simpsons at Universal Orlando resort.
About Twentieth Century Fox Consumer Products:
A division of 21st Century Fox and recognized industry leader, Twentieth Century Fox Consumer Products licenses and markets properties worldwide on behalf of Twentieth Century Fox Film Corporation, Twentieth Century Fox Television and Fox Broadcasting Company, as well as third party lines. The division is aligned with Twentieth Century Fox Television, the flagship studio leading the industry in supplying award-winning and blockbuster primetime television programming and entertainment content.
About Village Roadshow Theme Parks
Part of Village Roadshow Limited, a leading international entertainment and media company, Village Roadshow Theme Parks (VRTP) is an international theme park operator with operations in Australia, the United States and China. The Company is Australia’s largest theme park operator with Warner Bros. Movie World, Sea World, Wet’n’Wild Gold Coast, Paradise Country, Australian Outback Spectacular, Village Roadshow Studios, Sea World Resort and the country’s newest theme park Wet’n’Wild Sydney. In the United States, VRTP is the majority owner and operator of Wet’n’Wild Las Vegas in Nevada. VRTP also is advising on design and construction of a new mega park development, including a water park and marine park, on Hainan Island in China and will subsequently operate the parks under a management agreement.
Erin O’Brien, 20th Century Fox
Gyeongsangnam-do Provincial Government
BioSpain 2014 Expands its Investment Forum Through Wider Range of Investor Profiles and more Participating Companies
MADRID, July 16, 2014 /PRNewswire/ — Biospain 2014 is currently seeking and selecting projects for presentation as part of its Investment Forum, one of the most high profile in the sector, for which 25 investment funds – 70% of which are international…
Hollywood Actor Robert Downey Jr., Pop Superstar Bruno Mars and Comedienne Ellen DeGeneres Are the Newest Stars on ChiKuu.com
HONG KONG, July 15, 2014 /PRNewswire/ — Robert Downey Jr., Bruno Mars and Ellen DeGeneres are some of the brightest internationally-acclaimed stars today. Robert Downey Jr. is the epitome of the Iron Man character and has won a multitude of awards for his work. Bruno Mars is a two-time Grammy Award winner who is also the most played pop artist of 2013, and Ellen DeGeneres is a comedienne and talk show host extraordinaire who is known for her successful daytime talk show “Ellen“.
All three stars are vibrant and talented performers and they are also some of the most followed celebrities on Twitter. Robert Downey Jr. joined Twitter in April 2014 in the midst of shooting “Avengers: Age of Ultron” and rocked the Twitterverse, gaining approximately 244,000 followers 59 minutes after his first tweet. He currently has 1.87 million followers. Ellen DeGeneres fits in all her wonderful humor in 140 characters and tweets to her 29.2 million followers and Bruno Mars enthusiastically keeps his loyal 18.4 million followers up to date of his whereabouts and candid thoughts.
Aside from being social media rock stars, what else do Robert Downey Jr., Bruno Mars, and Ellen DeGeneres have in common? These three Hollywood heavyweights are the newest stars on the entertainment and English language-learning website http://ChiKuu.com.
If you love getting the latest gossip, and at the same time, are passionate about learning or improving your English, ChiKuu.com will easily be one of your favorite destinations on the web. ChiKuu.com is a fun website that makes it easier than ever to follow your favorite famous personalities through their funny, dramatic and often revealing tweets. If you want to be among the first to hear about Robert Downey Jr.’s next movie, Bruno Mars’ next tour, or simply Ellen DeGeneres’ funny thoughts for the day, follow these celebrities on ChiKuu.com.
Learning English is also fun with ChiKuu, a site that entertains while it educates. ChiKuu.com translates celebrity tweets into Chinese and Japanese and provides context to the tweet and an explanation of English idioms and expressions used. ChiKuu also provides background information about its featured stars. Users get their daily dose of celebrity news while getting the English language learning help they need.
ChiKuu.com is both Apple and PC compatible and is accessible through all your mobile devices. Join ChiKuu today.
*Twitter is a registered trademark of Twitter, Inc.
ChiKuu.com is not affiliated with or endorsed by any of the celebrities whose public messages are featured on the website.
ChiKuu.com is powered by Interush Media Inc. of Irvine, California. To learn more about Interush, visit http://www.interush.com.